IMMUNITYBIO INC

IBRXNASDAQ

🏆 #888 by market capEarnings Nov 2US Equity

$7.60▲ $0.11 (+1.47%)

🌅 Pre-market$7.67▲ 0.90%Regular close · extended-hours price shown

1h—

24h▲ 1.5%

7d▲ 4.8%

14d▲ 11.3%

30d▼ 2.6%

1y▲ 207.7%

🏦Market Cap

$7.96B

Small Cap

📈Revenue Growth (YoY)

+192.9%

High Growth

📊Gross Margin

99.3%

High

💵FCF Margin

—

⚖️P/S Ratio

47.5x

Expensive

Otter Score

47

Weak

Earnings

Q3 · 2026Reported 2026-08-04

Earnings Per Share

Actual

-0.22

Expected

-0.08

miss

−175.00%

YoY −120.00%

Revenue

Actual

$51.24M

Expected

$49.70M

beat

+3.10%

YoY +93.90%

Consensus estimates

Recent quarters

Q3 2026

-0.22

miss

Q2 2026

-0.62

miss

Q1 2026

-0.06

beat

Q4 2025

-0.07

beat